Genmab A/S GMAB Price Prediction

The determination to procure Genmab A/S is entirely contingent on your individualistic risk tolerance. As you may discern, Genmab A/S's value has experienced an escalation of 0.82% during the preceding 24 hours, and Genmab A/S has incurred a growth of 11% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Genmab A/S will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Genmab A/S may potentially surge to $32.59 by the end of this year. Looking at Genmab A/S's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $37.25. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Genmab A/S forecast, the price of Genmab A/S will increase by 1.36% over the next week and reach $30.98 by November 27, 2025.

Based on the our new experimental Genmab A/S forecast, the price of Genmab A/S will increase by 2.89% over the next month and reach $31.45 by December 20, 2025.

As per our most recent prediction on Genmab A/S's value in 2025, GMAB is anticipated to fluctuate within the range of $30.70 and $32.59. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Genmab A/S price forecast fails to consider sudden and extreme price fluctuations.

Genmab A/S's future appears to be on an upward trend, with an maximum price of $37.25 projected after a period of five years. Based on the Genmab A/S forecast for 2030, Genmab A/S's value may potentially reach its highest peak of approximately $37.25, while its lowest peak is anticipated to be around $31.31.

Based on the our new experimental Genmab A/S price prediction simulation, GMAB’s value in 2025 expected to grow by 6.62% to $32.59 if the best happened. The price will be between $32.59 and $30.70 during 2025.

According to our latest experimental simulation for Genmab A/S price prediction, GMAB’s value could rise by 27.25% to $38.89 in 2026, assuming the most favorable conditions. The price is projected to fluctuate between $38.89 and $32.51 throughout the year.

Our new experimental Genmab A/S price prediction model suggests that GMAB’s value in 2027 could increase by 32.11% , reaching $40.38 in the best-case scenario. The price is expected to range between $40.38 and $35.08 during the year.

Based on our experimental forecast model, Genmab A/S's value may experience a 19.26% growth in 2028, potentially reaching $36.45 under optimal conditions. The predicted price range for 2028 lies between $36.45 and $29.60.

Using our new experimental simulation for Genmab A/S price predictions, GMAB’s value in 2029 is expected to rise by 9.32% , reaching $33.41 in the best scenario. The price is forecasted to range between $33.41 and $29.64 over the course of 2029.

Our experimental simulation indicates that Genmab A/S’s price could grow by 21.86% in 2030, potentially hitting $37.25 under ideal conditions. The price will likely fluctuate between $37.25 and $31.31 during the year.

Based on the findings from our latest experimental Genmab A/S price prediction, GMAB could see a 26.06% rise in value, reaching $38.53 if the most positive scenario plays out in 2031. The price is expected to stay within a range of $38.53 and $35.67 throughout the year.

According to our experimental Genmab A/S price prediction, GMAB’s value is anticipated to rise by 40.47% in 2032, with the highest potential price being $42.94. Throughout the year, GMAB’s price could range from $42.94 and $37.87.

The results from our new Genmab A/S price prediction simulation suggest that GMAB may rise by 61.76% in 2033, potentially reaching $49.44 under the best circumstances. The predicted price range for the year is between $49.44 and $43.04.

Based on our experimental forecast for Genmab A/S’s price, GMAB could grow by 77.49% , with the value potentially hitting $54.25 in 2034. The expected price range for the year lies between $54.25 and $48.14.

Our recent Genmab A/S price prediction simulation suggests that GMAB’s value might rise by 103.6% in 2035, possibly reaching $62.24 if conditions are optimal. The expected price range for 2035 is between $62.24 and $52.21.

According to the experimental simulation, Genmab A/S’s value could rise by 151.11% in 2036, with a high of $76.76 under favorable conditions. The price is expected to fall between $76.76 and $60.27 over the course of the year.